Displaying 10 out of 28 results

  1. Workers of Teva Pharmaceutical Industries stand at the entrance to their facility in Ashdod, Israel

    Teva, Amgen end dispute over generic Cinacalcet HCl tablets

    Teva Pharmaceutical Industries Ltd said on Thursday it will pay an undisclosed amount to settle an ongoing dispute with Amgen Inc over its ...
  2. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Amgen, Novartis kick off fight for AbbVie blockbuster drug in EU

  3. FILE PHOTO: An Amgen sign is seen at the company's office in South San Francisco

    Amgen quarterly profit beats Wall Street view on new product sales

    Amgen Inc on Thursday reported a better-than-expected second quarter profit and raised its full-year forecast, as growth of newer drugs like ...
  4. New Content Item

    Amgen's new migraine drug hits insurance hurdles

  5. New Content Item

    FDA approves Mylan's biosimilar to Neulasta

  6. FILE PHOTO: Swiss drugmaker Novartis' logo is seen in Stein

    Novartis readies anti-sexism message for migraine drug

    With women hardest hit by migraine headaches, Swiss drugmaker Novartis is gearing up its marketing message to counteract sexism that it worries ...
  7. A man exits the Swiss drugmaker Novartis offices in Athens

    Novartis, aiming to go toe-to-toe with Humira, wins EU panel nod

    Novartis's generics unit on Friday won a European panel's recommendation for its biosimilar version of AbbVie's Humira as the Swiss drugmaker aims ...
  8. NYSE Aug 10

    US stocks tumble on North Korea worries

  9. NYSE 400

    US stocks pressured by trade-war worries

    Wall Street stocks finished modestly lower on Friday (Mar 17) as worries about international trade hung over the first meeting between President ...
  10. New Content Item

    Weak earnings, Trump fears pressure US stocks

    The Dow retreated on Tuesday as US stocks remained pressured following lacklustre earnings from ExxonMobil and uncertainty over the Trump growth ...